Dynamic microRNAome profiles in the developing porcine liverFootnote

Abbreviations: BP, biological processes; DE, differentially expressed; GO, gene ontology; hESCs, human embryonic stem cells; HSC, hepatic stellate cell; NE, normalized expression.

References

• Calmont A, Wandzioch E, Tremblay KD, et al. An FGF response pathway that mediates hepatic gene induction in embryonic endoderm cells. Dev. Cell. 2006;11:339–348.10.1016/j.devcel.2006.06.015
   PubMed Web of Science ®Google Scholar
• Agarwal S, Holton KL, Lanza R. Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells. 2008;26:1117–1127.10.1634/stemcells.2007-1102
   PubMed Web of Science ®Google Scholar
• Yin C, Evason KJ, Asahina K, et al. Hepatic stellate cells in liver development, regeneration, and cancer. J. Clin. Invest. 2013;123:1902–1910.10.1172/JCI66369
   PubMed Web of Science ®Google Scholar
• Brawand D, Soumillon M, Necsulea A, et al. The evolution of gene expression levels in mammalian organs. Nature. 2011;478:343–348.10.1038/nature10532
   PubMed Web of Science ®Google Scholar
• Tzur G, Israel A, Levy A, et al. Comprehensive gene and microRNA expression profiling reveals a role for micrornas in human liver development. PLoS One. 2009;4:e7511.10.1371/journal.pone.0007511
   PubMed Web of Science ®Google Scholar
• Tsai W-C, Hsu S-D, Hsu C-S, et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest. 2012;122:2884–2897.10.1172/JCI63455
   PubMed Web of Science ®Google Scholar
• Yin S, Fan Y, Zhang H, et al. Differential TGFβ pathway targeting by miR-122 in humans and mice affects liver cancer metastasis. Nat. Commun. 2016;7:11012.10.1038/ncomms11012
   PubMed Web of Science ®Google Scholar
• Zaret KS. Regulatory phases of early liver development: paradigms of organogenesis. Nat. Rev. Genet. 2002;3:499–512.10.1038/nrg837
   PubMed Web of Science ®Google Scholar
• Gün G, Kues WA. Current progress of genetically engineered pig models for biomedical research. Biores. Open Access. 2014;3:255–264.
   PubMedGoogle Scholar
• Bassols A, Costa C, Eckersall PD, et al. The pig as an animal model for human pathologies: a proteomics perspective. Proteomics Clin. Appl. 2014;8:715–731.10.1002/prca.201300099
   PubMed Web of Science ®Google Scholar
• Summerfield A, Meurens F, Ricklin ME. The immunology of the porcine skin and its value as a model for human skin. Mol. Immunol. 2015;66:14–21.10.1016/j.molimm.2014.10.023
   PubMed Web of Science ®Google Scholar
• Spurlock ME, Gabler NK. The development of porcine models of obesity and the metabolic syndrome. J. Nutr. 2008;138:397–402.
   PubMed Web of Science ®Google Scholar
• van der Merwe M, Ewing H, Caminita F, et al. The preterm pig as a model for acute lung disease after preterm birth (668.3). FASEB J. 2014;28: 668.3.
   Web of Science ®Google Scholar
• Hickey RD, Mao SA, Glorioso J, et al. Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease. Stem Cell Res. 2014;13:144–153.10.1016/j.scr.2014.05.003
   PubMed Web of Science ®Google Scholar
• Bigham A, Bauchet M, Pinto D, et al. Identifying signatures of natural selection in Tibetan and Andean populations using dense genome scan data. PLoS Genet. 2010;6:e1001116.10.1371/journal.pgen.1001116
   PubMed Web of Science ®Google Scholar
• Li M, Liu Y, Wang T, et al. Repertoire of porcine microRNAs in adult ovary and testis by deep sequencing. Int. J. Biol. Sci. 2011;7:1045–1055.10.7150/ijbs.7.1045
   PubMed Web of Science ®Google Scholar
• Krek A, Grün D, Poy MN, et al. Combinatorial microRNA target predictions. Nat. Genet. 2005;37:495–500.10.1038/ng1536
   PubMed Web of Science ®Google Scholar
• Lewis BP, Shih I-h, Jones-Rhoades MW, et al. Prediction of mammalian MicroRNA targets. Cell. 2003;115:787–798.10.1016/S0092-8674(03)01018-3
   PubMed Web of Science ®Google Scholar
• Ma J, Yu S, Wang F, et al. MicroRNA transcriptomes relate intermuscular adipose tissue to metabolic risk. Int. J. Mol. Sci. 2013;14:8611–8624.10.3390/ijms14048611
   PubMed Web of Science ®Google Scholar
• Ambros V, Bartel B, Bartel DP, et al. A uniform system for microRNA annotation. RNA. 2003;9:277–279.10.1261/rna.2183803
   PubMed Web of Science ®Google Scholar
• Lagos-Quintana M, Rauhut R, Lendeckel W, et al. Identification of novel genes coding for small expressed RNAs. Science. 2001;294:853–858.10.1126/science.1064921
   PubMed Web of Science ®Google Scholar
• Copley MR, Babovic S, Benz C, et al. The Lin28b–let-7–Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells. Nat. Cell Biol. 2013;15:916–925.10.1038/ncb2783
   PubMed Web of Science ®Google Scholar
• Roy S, Benz F, Alder J, et al. Down-regulation of miR-192-5p protects from oxidative-stress induced-acute liver injury. Clin. Sci. 2016;130:1197–1207.
   PubMed Web of Science ®Google Scholar
• Silakit R, Loilome W, Yongvanit P, et al. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator. J. Hepatobiliary Pancreat. Sci. 2014;21:864–872.10.1002/jhbp.2014.21.issue-12
   PubMed Web of Science ®Google Scholar
• Damania P, Sen B, Dar SB, et al. Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN). PLoS One. 2014;9:e91745.10.1371/journal.pone.0091745
   PubMed Web of Science ®Google Scholar
• Zhang J, Jin H, Liu H, et al. MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma. Oncogenesis. 2014;3:e97.10.1038/oncsis.2014.11
   PubMed Web of Science ®Google Scholar
• Bandiera S, Pfeffer S, Baumert TF, et al. miR-122 – a key factor and therapeutic target in liver disease. J. Hepatol. 2015;62:448–457.10.1016/j.jhep.2014.10.004
   PubMed Web of Science ®Google Scholar
• Waring J, Dumas E, Abel S, et al. Serum miR-122 may serve as a biomarker for response to direct acting antivirals: effect of paritaprevir/R with dasabuvir or ombitasvir on miR-122 in HCV-infected subjects. J. Viral Hepat. 2016;23:96–104.10.1111/jvh.12470
   PubMed Web of Science ®Google Scholar
• Ma D-N, Chai Z-T, Zhu X-D, et al. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2. J. Hematol. Oncol. 2016;9:1–10.10.1186/s13045-015-0229-y
   PubMed Web of Science ®Google Scholar
• Xin M, Small EM, Sutherland LB, et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 2009;23:2166–2178.10.1101/gad.1842409
   PubMed Web of Science ®Google Scholar
• Meng Z, Fu X, Chen X, et al. miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology. 2010;52:2148–2157.10.1002/hep.23915
   PubMed Web of Science ®Google Scholar
• Yao J, Liang L, Huang S, et al. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology. 2010;51:846–856.
   PubMed Web of Science ®Google Scholar
• Jung CJ, Iyengar S, Blahnik KR, et al. Human ESC self-renewal promoting microRNAs induce epithelial-mesenchymal transition in hepatocytes by controlling the PTEN and TGFβ tumor suppressor signaling pathways. Mol. Cancer Res. 2012;10:979–991.10.1158/1541-7786.MCR-11-0421
   PubMed Web of Science ®Google Scholar
• Yuan Q, Loya K, Rani B, et al. MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration. Hepatology. 2013;57:299–310.10.1002/hep.25984
   PubMed Web of Science ®Google Scholar
• Hand NJ, Master ZR, Eauclaire SF, et al. The microRNA-30 family is required for vertebrate hepatobiliary development. Gastroenterology. 2009;136:1081–1090.10.1053/j.gastro.2008.12.006
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang H, Liu J, et al. miR-30 inhibits TGF-β1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Biochem. Biophys. Res. Commun. 2012;417:1100–1105.10.1016/j.bbrc.2011.12.121
   PubMed Web of Science ®Google Scholar
• Hou J, Lin L, Zhou W, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell. 2011;19:232–243.10.1016/j.ccr.2011.01.001
   PubMed Web of Science ®Google Scholar
• Ji J, Zhang J, Huang G, et al. Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett. 2009;583:759–766.10.1016/j.febslet.2009.01.034
   PubMed Web of Science ®Google Scholar
• Jordan SD, Krüger M, Willmes DM, et al. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat. Cell Biol. 2011;13:434–446.10.1038/ncb2211
   PubMed Web of Science ®Google Scholar
• Zhu H, Shyh-Chang N, Segrè AV, et al. The Lin28/let-7 axis regulates glucose metabolism. Cell. 2011;147:81–94.10.1016/j.cell.2011.08.033
   PubMed Web of Science ®Google Scholar
• Carver RS, Stevenson MC, Scheving LA, et al. Diverse expression of ErbB receptor proteins during rat liver development and regeneration. Gastroenterology. 2002;123:2017–2027.10.1053/gast.2002.37060
   PubMed Web of Science ®Google Scholar
• Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410:37–40.10.1038/35065000
   PubMed Web of Science ®Google Scholar